Neuropsychological impairments predict the clinical course in schizophrenia

European Archives of Psychiatry and Clinical Neuroscience
Wolfgang WölwerGerman Study Group on First Episode Schizophrenia

Abstract

To add to the open question whether cognitive impairments predict clinical outcome in schizophrenia, a sample of 125 first episode patients was assessed at the onset and over one year of controlled long-term treatment within a study of the German Research Network on Schizophrenia. No relapse according to predefined criteria occurred within the first year, but a total of 29 patients fulfilled post-hoc criteria of "clinical deterioration". Impairments in cognitive functioning assessed by the Trail-Making Test B at the onset of long-term treatment differentiated between patients with vs. without later clinical deterioration and proved to be a significant predictor of the clinical course in a regression analysis outperforming initial clinical status as predictor. However, low sensitivity (72%) and specificity (51%) limit possibilities of a transfer to individual predictions. As a linear combination of neuropsychological and psychopathological variables obtained highest predictive validity, such a combination may improve the prediction of the course of schizophrenic disorders and may ultimately lead to a more efficient and comprehensive treatment planning.

References

Feb 1, 1994·Archives of General Psychiatry·A J SaykinRaquel E Gur
Jul 1, 1994·Journal of Clinical Psychology·J P O'DonnellJ J Romero
Aug 1, 1994·Archives of General Psychiatry·T D CannonR A Price
Feb 1, 1997·Archives of General Psychiatry·J M GoldD R Weinberger
Jul 23, 1998·Neuropsychology·R W Heinrichs, K K Zakzanis
Oct 28, 1998·Schizophrenia Research·M J CuestaA Zarzuela
Oct 26, 1999·Development and Psychopathology·Barbara A CornblattL Erlenmeyer-Kimling
Sep 6, 2000·The Journal of Nervous and Mental Disease·D I VelliganL C Halgunseth
Mar 20, 2001·Critical Reviews in Neurobiology·B Elvevåg, T E Goldberg
Dec 4, 2001·Acta Psychiatrica Scandinavica. Supplementum·R W Gråwe, S Levander
Jan 5, 2002·The New England Journal of Medicine·John G CsernanskyRisperidone-USA-79 Study Group
Feb 4, 2003·European Archives of Psychiatry and Clinical Neuroscience·Margot AlbusFritz Mohr
Jan 10, 2004·European Archives of Psychiatry and Clinical Neuroscience·Wolfgang WölwerWolfgang Gaebel
Dec 31, 2004·The American Journal of Psychiatry·Warrick J BrewerPatrick D McGorry
Feb 8, 2005·Schizophrenia Research·Matthew M Kurtz
Mar 23, 2005·Biological Psychiatry·Richard S E KeefeMargaret P Poe
Dec 6, 2005·Biological Psychiatry·Todd LenczBarbara A Cornblatt
Aug 26, 2006·Schizophrenia Research·Richard S E KeefeJeffery A Lieberman
Sep 13, 2006·The Journal of Clinical Psychiatry·Michael F Green
Nov 15, 2006·Schizophrenia Bulletin·Raquel E GurWilliam S Stone
Dec 5, 2006·Psychiatry Research·Esther A E HolthausenRobert J van den Bosch
Nov 9, 2007·European Archives of Psychiatry and Clinical Neuroscience·Andreas WittorfStefan Klingberg
Mar 12, 2008·Current Opinion in Psychiatry·Robin EmsleyRenata Schoeman
Apr 2, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Andrei SzökeMarion Leboyer
May 7, 2008·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·David L BraffInvestigators of the Consortium on the Genetics of Schizophrenia
Jul 2, 2008·Expert Review of Neurotherapeutics·Caroline Demily, Nicolas Franck

Citations

Oct 31, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Nikolaos KoutsoulerisWolfgang Maier
May 30, 2009·European Archives of Psychiatry and Clinical Neuroscience·Mats BogrenPer Nettelbladt
Jun 15, 2013·Neuropsychiatric Disease and Treatment·Tomomi TenjinNoboru Yamaguchi
Nov 1, 2013·European Archives of Psychiatry and Clinical Neuroscience·Elsa GilbertMichel Maziade
Jun 12, 2012·Comprehensive Psychiatry·Maarten J V PetersHarald Merckelbach
Sep 10, 2010·Schizophrenia Research·Nikolaos KoutsoulerisEva M Meisenzahl
Jan 27, 2012·Human Psychopharmacology·Tomomi TenjinNoboru Yamaguchi
Aug 28, 2013·Schizophrenia Research·Wolfgang Gaebel, Mathias Riesbeck
Aug 21, 2012·Psychiatry Research·Wolfgang WölwerWolfgang Gaebel
Nov 6, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Irina BenaigesAna Adan
Feb 16, 2011·The Australian and New Zealand Journal of Psychiatry·Vasilis P Bozikas, Christina Andreou
Jul 18, 2017·World Journal of Psychiatry·Silvia GrassiMassimiliano Buoli
Jun 17, 2016·Psychological Medicine·Christy Lai-Ming HuiEric Yu-Hai Chen
Apr 22, 2019·The Cochrane Database of Systematic Reviews·Adib EssaliNawar AlMounayer
Mar 10, 2016·Harvard Review of Psychiatry·Urs HeilbronnerThomas G Schulze
Dec 16, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Rüdiger J SeitzJürgen Zielasek
Oct 31, 2018·Psychological Medicine·Christy Lm HuiEric Yh Chen

Related Concepts

Overinclusion
Double-Blind Method
Haldol
Longitudinal Survey
Memory for Designs Test
Receiver Operating Characteristic
Schizophrenia
Antipsychotic Effect
Logistic Regression
Nested Case-Control Studies

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.